Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.763 | 0.360 | 3 | 122120794 | 3 prime UTR variant | G/A;C | snv |
|
Digestive System Diseases; Neoplasms | 0.030 | 1.000 | 3 | 2011 | 2019 | ||||||||
|
1.000 | 0.080 | 3 | 122077921 | splice region variant | G/A | snv | 7.0E-02 |
|
Immune System Diseases; Nervous System Diseases | 0.820 | 1.000 | 3 | 2011 | 2018 | |||||||
|
0.763 | 0.360 | 3 | 122120794 | 3 prime UTR variant | G/A;C | snv |
|
0.020 | 1.000 | 2 | 2011 | 2014 | |||||||||
|
0.925 | 0.080 | 3 | 122119944 | 3 prime UTR variant | T/C | snv |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.020 | 1.000 | 2 | 2015 | 2018 | ||||||||
|
0.925 | 0.080 | 3 | 122119944 | 3 prime UTR variant | T/C | snv |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.020 | 1.000 | 2 | 2015 | 2018 | ||||||||
|
0.763 | 0.360 | 3 | 122120794 | 3 prime UTR variant | G/A;C | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.763 | 0.360 | 3 | 122120794 | 3 prime UTR variant | G/A;C | snv |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.763 | 0.360 | 3 | 122120794 | 3 prime UTR variant | G/A;C | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.763 | 0.360 | 3 | 122120794 | 3 prime UTR variant | G/A;C | snv |
|
Digestive System Diseases; Neoplasms; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.763 | 0.360 | 3 | 122120794 | 3 prime UTR variant | G/A;C | snv |
|
Infections | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.763 | 0.360 | 3 | 122120794 | 3 prime UTR variant | G/A;C | snv |
|
Digestive System Diseases; Neoplasms; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.763 | 0.360 | 3 | 122120794 | 3 prime UTR variant | G/A;C | snv |
|
Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.763 | 0.360 | 3 | 122120794 | 3 prime UTR variant | G/A;C | snv |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.763 | 0.360 | 3 | 122120794 | 3 prime UTR variant | G/A;C | snv |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.925 | 0.080 | 3 | 122102296 | intron variant | T/A;G | snv |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.925 | 0.080 | 3 | 122102296 | intron variant | T/A;G | snv |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.925 | 0.120 | 3 | 122098766 | intron variant | G/A | snv | 0.26 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.120 | 3 | 122098766 | intron variant | G/A | snv | 0.26 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2014 | 2014 | |||||||
|
3 | 122062876 | intron variant | T/C | snv | 0.19 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.080 | 3 | 122074340 | intron variant | C/A;T | snv |
|
Immune System Diseases; Nervous System Diseases | 0.800 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.882 | 0.120 | 3 | 122081640 | intron variant | A/C | snv | 0.31 |
|
Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.882 | 0.120 | 3 | 122081640 | intron variant | A/C | snv | 0.31 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.882 | 0.120 | 3 | 122081640 | intron variant | A/C | snv | 0.31 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 | |||||||
|
0.882 | 0.120 | 3 | 122106342 | missense variant | A/G;T | snv | 4.0E-06; 4.0E-06 |
|
Infections; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2001 | 2001 | |||||||
|
0.882 | 0.120 | 3 | 122106342 | missense variant | A/G;T | snv | 4.0E-06; 4.0E-06 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2001 | 2001 |